NCT00700765View on ClinicalTrials.gov

Observational Study to Evaluate Safety of Levemir® in Type 1 and Type 2 Diabetes

CompletedOBSERVATIONAL
Enrollment

1,531

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Interventions
DRUG

insulin detemir

For study drug, start dose and frequency of administration to be prescribed by the physician as a result of normal clinical evaluation

Trial Locations (1)

12520

Novo Nordisk Investigational Site, Jakarta

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY